Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Iteos Therapeutics Inc

ITOS
Current price
9.84 USD -0.29 USD (-2.86%)
Last closed 10.1 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 354 271 488 USD
Yield for 12 month -48.51 %
Week
Month
Year
ITOS
21.11.2021 - 28.11.2021

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc"R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts. Address: 321 Arsenal Street, Cambridge, MA, United States, 02472-5710

Analytics

WallStreet Target Price

37.4 USD

P/E ratio

Dividend Yield

Current Year

+267 630 000 USD

Last Year

+344 775 000 USD

Current Quarter

Last Quarter

Current Year

+267 630 000 USD

Last Year

+344 775 000 USD

Current Quarter

Last Quarter

Key Figures ITOS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -91 190 000 USD
Operating Margin TTM -138.47 %
PE Ratio
Return On Assets TTM -7.91 %
PEG Ratio
Return On Equity TTM -10 %
Wall Street Target Price 37.4 USD
Revenue TTM 66 500 000 USD
Book Value 16.72 USD
Revenue Per Share TTM 1.86 USD
Dividend Share
Quarterly Revenue Growth YOY -91.7 %
Dividend Yield
Gross Profit TTM 267 630 000 USD
Earnings Share -1.75 USD
Diluted Eps TTM -1.75 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -88.6 %
Profit Margin -92.69 %

Dividend Analytics ITOS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ITOS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ITOS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 12.5628
Enterprise Value Revenue 0.0111
Price Sales TTM 5.3274
Enterprise Value EBITDA 2.7184
Price Book MRQ 0.5916

Financials ITOS

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ITOS

For 52 weeks

8.2 USD 23 USD
50 Day MA 9.83 USD
Shares Short Prior Month 1 746 070
200 Day MA 13.03 USD
Short Ratio 2.48
Shares Short 1 586 366
Short Percent 7.87 %